Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CYP2C9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CYP2C8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CYP2C19 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CYP2C18 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PDLIM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HELLS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TBC1D12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SORBS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on